STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mayo clinic tests 'Trained' immune cells to fight inoperable liver cancer
Disease control Recruiting nowThis study is testing a new combination treatment for advanced liver cancer that cannot be removed by surgery. Doctors take a patient's own immune cells, grow and train them in a lab to attack cancer, and then inject them directly into the tumor after radiation therapy. The goal …
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radiation beads & immune drugs: new hope for tough liver cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a three-part treatment for advanced bile duct cancer in the liver that cannot be removed by surgery. Doctors combine a targeted radiation treatment (Y90 radioembolization) with two immunotherapy drugs (tremelimumab and durvalumab) t…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC